United Therapeutics buy UBS Group AG
Start price
06.01.26
/
50%
€426.10
Target price
06.01.27
€550.12
Performance (%)
-4.53%
Price
17.02.26
€407.20
Summary
This prediction is currently active. With a performance of -4.53%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 06.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 2.389% | 2.389% |
| iShares Core DAX® | 0.193% | -1.216% |
| iShares Nasdaq 100 | -1.353% | -5.307% |
| iShares Nikkei 225® | -0.426% | 7.319% |
| iShares S&P 500 | -1.008% | -3.400% |
Comments by UBS_Group_AG for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (NASDAQ:UTHR) was given a new $645.00 price target on by analysts at UBS Group AG. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by UBS_Group_AG for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€393.20
06.11.25
06.11.25
€521.34
06.11.26
06.11.26
3.56%
17.02.26
17.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€360.40
29.09.25
29.09.25
€494.80
29.09.26
29.09.26
12.99%
17.02.26
17.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€337.60
04.09.25
04.09.25
€480.20
04.09.26
04.09.26
20.62%
17.02.26
17.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€258.80
13.08.25
13.08.25
€355.41
13.08.26
13.08.26
57.34%
17.02.26
17.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€244.10
30.06.25
30.06.25
€328.48
30.06.26
30.06.26
66.82%
17.02.26
17.02.26
United Therapeutics
Start price
Target price
Perf. (%)
€355.30
08.01.25
08.01.25
€460.94
08.01.26
08.01.26
17.73%
09.01.26
09.01.26
United Therapeutics
Start price
Target price
Perf. (%)
€292.80
08.07.24
08.07.24
€341.51
08.07.25
08.07.25
-14.82%
09.07.25
09.07.25